These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 26827137)

  • 1. Preclinical toxicity evaluation of JD5037, a peripherally restricted CB
    Kale VP; Gibbs S; Taylor JA; Zmarowski A; Novak J; Patton K; Sparrow B; Gorospe J; Anand S; Cinar R; Kunos G; Chorvat RJ; Terse PS
    Regul Toxicol Pharmacol; 2019 Dec; 109():104483. PubMed ID: 31580887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy in diet-induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837.
    Cooper ME; Nørregaard PK; Högberg T; Andersson G; Receveur JM; Linget JM; Elling CE
    Br J Pharmacol; 2024 Jun; ():. PubMed ID: 38886096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One for the Price of Two…Are Bivalent Ligands Targeting Cannabinoid Receptor Dimers Capable of Simultaneously Binding to both Receptors?
    Glass M; Govindpani K; Furkert DP; Hurst DP; Reggio PH; Flanagan JU
    Trends Pharmacol Sci; 2016 May; 37(5):353-363. PubMed ID: 26917061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
    Navarro G; Sotelo E; Raïch I; Loza MI; Brea J; Majellaro M
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 1,3-disubstituted pyrazole peripheral cannabinoid receptor partial agonists.
    Amato G; Runyon S; Vasukuttan V; Decker AM; Gay EA; Laudermilk L; Maitra R
    Bioorg Med Chem Lett; 2023 Sep; 93():129430. PubMed ID: 37543275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid Signaling in Kidney Disease.
    Arceri L; Nguyen TK; Gibson S; Baker S; Wingert RA
    Cells; 2023 May; 12(10):. PubMed ID: 37408253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Photo-Rimonabant": Synthesis and Biological Evaluation of Novel Photoswitchable Molecules Derived from Rimonabant Lead to a Highly Selective and Nanomolar "
    Rodríguez-Soacha DA; Fender J; Ramírez YA; Collado JA; Muñoz E; Maitra R; Sotriffer C; Lorenz K; Decker M
    ACS Chem Neurosci; 2021 May; 12(9):1632-1647. PubMed ID: 33856764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo.
    Scheiner M; Dolles D; Gunesch S; Hoffmann M; Nabissi M; Marinelli O; Naldi M; Bartolini M; Petralla S; Poeta E; Monti B; Falkeis C; Vieth M; Hübner H; Gmeiner P; Maitra R; Maurice T; Decker M
    J Med Chem; 2019 Oct; 62(20):9078-9102. PubMed ID: 31609608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development.
    Nguyen T; Thomas BF; Zhang Y
    Curr Top Med Chem; 2019; 19(16):1418-1435. PubMed ID: 31284863
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Hirsch S; Tam J
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31096702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice.
    Chen W; Shui F; Liu C; Zhou X; Li W; Zheng Z; Fu W; Wang L
    Front Pharmacol; 2017; 8():707. PubMed ID: 29051736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antimicrobial studies of novel derivatives of 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)benzoic acid as potent anti-Acinetobacter baumannii agents.
    Allison D; Delancey E; Ramey H; Williams C; Alsharif ZA; Al-Khattabi H; Ontko A; Gilmore D; Alam MA
    Bioorg Med Chem Lett; 2017 Feb; 27(3):387-392. PubMed ID: 28065568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological characterization of functionalized 6-piperazin-1-yl-purines as cannabinoid receptor 1 (CB1) inverse agonists.
    Amato GS; Manke A; Vasukuttan V; Wiethe RW; Snyder RW; Runyon SP; Maitra R
    Bioorg Med Chem; 2018 Aug; 26(15):4518-4531. PubMed ID: 30077609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel, brain-penetrating CB1 receptor inverse agonist: metabolic profile in diet-induced obese models and aspects of central activity.
    Jacobson LH; Commerford SR; Gerber SP; Chen YA; Dardik B; Chaperon F; Schwartzkopf C; Nguyen-Tran V; Hollenbeck T; McNamara P; He X; Liu H; Seidel HM; Jaton AL; Gromada J; Teixeira S
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec; 384(6):565-81. PubMed ID: 21947251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control.
    Son MH; Kim HD; Chae YN; Kim MK; Shin CY; Ahn GJ; Choi SH; Yang EK; Park KJ; Chae HW; Moon HS; Kim SH; Shin YG; Yoon SH
    Int J Obes (Lond); 2010 Mar; 34(3):547-56. PubMed ID: 20029379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripherally restricted CB1 receptor blockers.
    Chorvat RJ
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4751-60. PubMed ID: 23902803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.
    Pavón FJ; Serrano A; Pérez-Valero V; Jagerovic N; Hernández-Folgado L; Bermúdez-Silva FJ; Macías M; Goya P; de Fonseca FR
    J Neuroendocrinol; 2008 May; 20 Suppl 1():116-23. PubMed ID: 18426510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazole antagonists of the CB1 receptor with reduced brain penetration.
    Fulp A; Zhang Y; Bortoff K; Seltzman H; Snyder R; Wiethe R; Amato G; Maitra R
    Bioorg Med Chem; 2016 Mar; 24(5):1063-70. PubMed ID: 26827137
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.